Immix... recnac latceroloc ni 011-XMI r-

Current Location: Home >DeFi >Immix... recnac latceroloc ni 011-XMI r Details

Immix... recnac latceroloc ni 011-XMI r

Date: 2025-06-10 05:54:04 Source: Author: NFTs & Metaverse Views: 559

Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

(Editor-in-Chief: Spotlight)

[1]

[2]

[3]

Previous: Companies... orc 31.242₹ ta eunever dna ero
Next: Owner... noitarepo gurd htiw tnemevlovn